Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide survey
Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide survey
复制标题
DOI：
10.1016/j.jhep.2012.11.009
复制
发表时间：
2013-04-01
影响因子：
25.7
通讯作者：
Matsuyama, Yutaka
中科院分区：
文献类型：
--
作者：
Hasegawa, Kiyoshi;Kokudo, Norihiro;Matsuyama, Yutaka
背景和目标：对于肝功能良好的早期或中晚期肝细胞癌（HCC）的治疗选择仍然存在争议。我们评估了手术切除（SR）、经皮无水乙醇注射（PEI）和射频消融（RFA）对HCC患者长期预后的治疗影响。方法：基于2000年至2005年期间接受SR、PEI或RFA治疗的28，510例HCC患者的日本全国调查构建的数据库用于识别12例，968例肿瘤不超过3个的患者（
Background & Aims: The treatment of choice for early or moderately advanced hepatocellular carcinoma (HCC) with good liver function remains controversial. We evaluated the therapeutic impacts of surgical resection (SR), percutaneous ethanol injection (PEI), and radiofrequency ablation (RFA) on long-term outcomes in patients with HCC.Methods: A database constructed on the basis of a Japanese nationwide survey of 28,510 patients with HCC treated by SR, PEI, or RFA between 2000 and 2005 was used to identify 12,968 patients who had no more than 3 tumors (